Related references
Note: Only part of the references are listed.Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
Efrat Flashner-Abramson et al.
THERANOSTICS (2019)
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
Zev A. Binder et al.
CANCER CELL (2018)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients
Javier M. Figueroa et al.
NEURO-ONCOLOGY (2017)
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
Maite Verreault et al.
CLINICAL CANCER RESEARCH (2016)
Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma
Genaro R. Villa et al.
NATURE NEUROSCIENCE (2016)
Intercellular signaling through secreted proteins induces free-energy gradient-directed cell movement
Nataly Kravchenko-Balasha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Origin of the U87MG glioma cell line: Good news and bad news
Marie Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes
Chris L. Smith et al.
CELL REPORTS (2016)
Dasatinib in recurrent glioblastoma: failure as a teacher
David Schiff et al.
NEURO-ONCOLOGY (2015)
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
Hongxiang Wang et al.
NEOPLASIA (2015)
Glioblastoma: Defining Tumor Niches
Dolores Hambardzumyan et al.
TRENDS IN CANCER (2015)
Glioblastoma: From Molecular Pathology to Targeted Treatment
Timothy F. Cloughesy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Glioblastoma cellular architectures are predicted through the characterization of two-cell interactions
Nataly Kravchenko-Balasha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The influence of surgery on recurrence pattern of glioblastoma
Pasquale De Bonis et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility
Jessica Ahn et al.
JOURNAL OF CELL SCIENCE (2012)
Glioblastoma-a moving target
Bengt Westermark
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors
Igor Vivanco et al.
CANCER DISCOVERY (2012)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
Maria-del-Mar Inda et al.
GENES & DEVELOPMENT (2010)
Plasticity of cell migration: a multiscale tuning model
Peter Friedl et al.
JOURNAL OF CELL BIOLOGY (2010)
Improving the prognosis for patients with glioblastoma: the rationale for targeting Src
John de Groot et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis
Muhammad H. Zaman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
